A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval
Clinical trial NCT01328054 · COMPLETED
Trial details
- NCT number
- NCT01328054
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2015-03-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.